• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养状况能否预测晚期非小细胞肺癌患者的总生存期?

Can Nutritional Status Predict Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer?

机构信息

Department of Clinical Korean Medicine, Graduate School, Kyung Hee University , Dongdaemun-gu , Republic of Korea.

Department of Medical Oncology & Hematology, College of Medicine, Kyung Hee University , Seoul , Republic of Korea.

出版信息

Nutr Cancer. 2019;71(7):1108-1117. doi: 10.1080/01635581.2019.1598564. Epub 2019 Apr 22.

DOI:10.1080/01635581.2019.1598564
PMID:31007069
Abstract

Medical records of patients with advanced non-small cell lung cancer (NSCLC) were retrospectively reviewed to examine the prognostic impact of nutritional status on survival. Age, sex, body mass index (BMI), Eastern Cooperative Oncology Group Performance Status (ECOG-PS), histologic tumor type, pulmonary comorbidities, white blood cell (WBC) count, C-reactive protein (CRP) level, and prognostic nutritional index (PNI) were assessed. Overall survival was calculated using Kaplan-Meier analysis and compared using log-rank testing. Univariate and multivariate Cox regression model analyses were used to evaluate prognostic impact. Of the 183 enrolled patients, 166 had stage IV NSCLC; 70 had ECOG-PS scores of 2; and 129 had undergone prior anticancer therapy. Age ≥ 65 years, male sex, smoking, BMI < 21 kg/m, ECOG-PS score of 2, WBC count > 11,000 cells/μL, CRP level > 1.0 mg/dL, and PNI ≤46.1 were associated with poor overall survival. Multivariate analysis revealed that BMI ≥ 21 kg/m (hazard ratio [HR], 0.64) and PNI > 46.1 (HR, 0.65) were associated with prolonged survival, while age ≥ 65 years (HR, 1.48) and CRP level > 1.0 mg/dL (HR, 1.82) were associated with poor survival. In conclusion, BMI and PNI, as indicators of nutritional status, were significant independent prognostic factors of survival.

摘要

回顾性分析了晚期非小细胞肺癌(NSCLC)患者的病历,以研究营养状况对生存预后的影响。评估了年龄、性别、体重指数(BMI)、东部肿瘤协作组体能状态(ECOG-PS)评分、组织学肿瘤类型、肺部合并症、白细胞(WBC)计数、C 反应蛋白(CRP)水平和预后营养指数(PNI)。采用 Kaplan-Meier 分析计算总生存期,并采用对数秩检验比较。采用单因素和多因素 Cox 回归模型分析评估预后影响。在 183 名入组患者中,166 名患有 IV 期 NSCLC;70 名 ECOG-PS 评分为 2;129 名患者接受了既往抗癌治疗。年龄≥65 岁、男性、吸烟、BMI<21kg/m、ECOG-PS 评分为 2、WBC 计数>11,000 细胞/μL、CRP 水平>1.0mg/dL 和 PNI≤46.1 与总生存期不良相关。多因素分析显示,BMI≥21kg/m(危险比 [HR],0.64)和 PNI>46.1(HR,0.65)与生存延长相关,而年龄≥65 岁(HR,1.48)和 CRP 水平>1.0mg/dL(HR,1.82)与生存不良相关。总之,BMI 和 PNI 作为营养状况的指标,是生存的独立预后因素。

相似文献

1
Can Nutritional Status Predict Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer?营养状况能否预测晚期非小细胞肺癌患者的总生存期?
Nutr Cancer. 2019;71(7):1108-1117. doi: 10.1080/01635581.2019.1598564. Epub 2019 Apr 22.
2
Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.治疗前预后营养指数作为一种新型生物标志物在接受免疫检查点抑制剂治疗的非小细胞肺癌患者中的应用。
Lung Cancer. 2019 Oct;136:45-51. doi: 10.1016/j.lungcan.2019.08.006. Epub 2019 Aug 14.
3
Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations.靶向治疗时代的营养状况:营养不良是表皮生长因子受体激活突变的非小细胞肺癌的一个预后因素。
Korean J Intern Med. 2016 Nov;31(6):1140-1149. doi: 10.3904/kjim.2015.062. Epub 2016 Mar 28.
4
Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs.低预后营养指数与晚期非小细胞肺癌患者接受表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs)治疗后的较差生存率相关。
PLoS One. 2016 Jan 19;11(1):e0147226. doi: 10.1371/journal.pone.0147226. eCollection 2016.
5
Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.C反应蛋白和吸烟对接受一线姑息化疗的晚期非小细胞肺癌患者的预后意义
J Thorac Oncol. 2009 Mar;4(3):326-32. doi: 10.1097/JTO.0b013e31819578c8.
6
Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.基于接受放化疗的局部晚期非小细胞肺癌患者全身炎症和营养状况的预后评分系统评估
J Radiat Res. 2018 Jan 1;59(1):50-57. doi: 10.1093/jrr/rrx060.
7
[Clinical application value of prognostic nutritional index for predicting survival in patients with advanced non-small cell lung cancer].[预后营养指数对预测晚期非小细胞肺癌患者生存的临床应用价值]
Zhonghua Zhong Liu Za Zhi. 2017 Feb 23;39(2):146-149. doi: 10.3760/cma.j.issn.0253-3766.2017.02.015.
8
Clinical Significance of Prognostic Nutritional Index After Surgical Treatment in Lung Cancer.肺癌手术治疗后预后营养指数的临床意义
Ann Thorac Surg. 2017 Jul;104(1):296-302. doi: 10.1016/j.athoracsur.2017.01.085. Epub 2017 Apr 19.
9
Prognostic factors in older patients with advanced non-small cell lung cancer in China.中国老年晚期非小细胞肺癌患者的预后因素
Tumori. 2014 Jan-Feb;100(1):69-74. doi: 10.1700/1430.15818.
10
The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.晚期非小细胞肺癌患者临床预后因素与表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)疗效的相关性:94例EGFR突变患者的回顾性评估
Oncotarget. 2017 Jan 10;8(2):3412-3421. doi: 10.18632/oncotarget.13787.

引用本文的文献

1
NRS2002 score as a prognostic factor in solid tumors treated with immune checkpoint inhibitor therapy: a real-world evidence analysis.NRS2002 评分作为免疫检查点抑制剂治疗实体瘤的预后因素:真实世界证据分析。
Cancer Biol Ther. 2024 Dec 31;25(1):2358551. doi: 10.1080/15384047.2024.2358551. Epub 2024 May 30.
2
Prognostic importance of prognostic nutritional index and modified Glasgow prognostic score in advanced lung cancer with targetable mutation.在有靶向突变的晚期肺癌中,预后营养指数和改良格拉斯哥预后评分的预后重要性。
J Cancer Res Clin Oncol. 2024 Apr 26;150(4):215. doi: 10.1007/s00432-023-05529-w.
3
Positive correlation between persistence of medical nutrition therapy and overall survival in patients with head and neck cancer.
头颈部癌症患者的医学营养疗法持续时间与总生存期呈正相关。
Pathol Oncol Res. 2024 Mar 15;30:1611664. doi: 10.3389/pore.2024.1611664. eCollection 2024.
4
Prognostic Value of Inflammation and Nutrition-Based Scores in Non-Small Cell Lung Cancer.炎症和营养评分在非小细胞肺癌中的预后价值
Med Princ Pract. 2024;33(2):122-132. doi: 10.1159/000535781. Epub 2023 Dec 13.
5
Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence.白蛋白相关炎症标志物在非小细胞肺癌预后中的研究进展及价值:临床证据综述。
Ann Med. 2023 Dec;55(1):1294-1307. doi: 10.1080/07853890.2023.2192047.
6
Real-world treatment pattern and prognostic factors of stage IV lung squamous cell carcinoma patients.IV 期肺鳞癌患者的真实世界治疗模式和预后因素。
Kaohsiung J Med Sci. 2022 Oct;38(10):1001-1011. doi: 10.1002/kjm2.12599.
7
A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study.一项基于营养相关因素的风险分层研究,旨在探索接受根治性放化疗的局部晚期食管鳞状细胞癌患者治疗中的临床获益:一项回顾性队列研究
Front Nutr. 2022 Aug 4;9:896847. doi: 10.3389/fnut.2022.896847. eCollection 2022.
8
Prognostic Nutritional Index Predicts Outcome of PD-L1 Negative and MSS Advanced Cancer Treated with PD-1 Inhibitors.预后营养指数预测 PD-L1 阴性和 MSS 晚期癌症患者接受 PD-1 抑制剂治疗的结局。
Biomed Res Int. 2022 Jun 6;2022:6743126. doi: 10.1155/2022/6743126. eCollection 2022.
9
Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis.卡铂与顺铂联合依托泊苷一线治疗小细胞肺癌的比较:一项汇总分析。
BMC Cancer. 2021 Dec 7;21(1):1308. doi: 10.1186/s12885-021-09034-6.
10
The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer.营养状况与局部晚期和晚期肺癌患者预后的关系。
Support Care Cancer. 2021 Jun;29(6):3357-3365. doi: 10.1007/s00520-020-05856-5. Epub 2020 Oct 30.